Fifteen years of work: The COMS outcomes for medium-sized choroidal melanoma

Archives of Ophthalmology

Volumn 119, Issue 7, 2001, Pages 1067-1068

  Sieving, P A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEAM THERAPY; CANCER INCIDENCE; CHOROID MELANOMA; EDITORIAL; ENUCLEATION; HUMAN; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT INDICATION;

EID: 0034947333     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.119.7.1067     Document Type: Editorial

References (6)

1. Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumor cells?
2. An evaluation of enucleation in the management of uveal melanoma
3. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: Initial mortality findings: COMS report No. 18
4. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: Characteristics of patients enrolled and not enrolled: COMS report No. 17
5. The collaborative ocular melanoma study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma, II: Initial mortality findings: COMS report No. 10
6. The ocular melanoma story: LIII Edward Jackson Memorial Lecture: Part II